Boulegeris Investments Has Trimmed Novartis A G (NVS) Holding, Penn Capital Management Co Has Increased Its Baxter Intl (BAX) Position

June 20, 2017 - By Hazel Jackson

Penn Capital Management Co Inc increased Baxter Intl Inc (BAX) stake by 105.38% reported in 2016Q4 SEC filing. Penn Capital Management Co Inc acquired 7,409 shares as Baxter Intl Inc (BAX)’s stock rose 15.04%. The Penn Capital Management Co Inc holds 14,440 shares with $1.67M value, up from 7,031 last quarter. Baxter Intl Inc now has $32.38 billion valuation. The stock increased 2.80% or $1.62 during the last trading session, reaching $59.55. About shares traded. Baxter International Inc (NYSE:BAX) has risen 32.55% since June 20, 2016 and is uptrending. It has outperformed by 15.85% the S&P500.

Boulegeris Investments Inc decreased Novartis A G (NVS) stake by 80.21% reported in 2016Q4 SEC filing. Boulegeris Investments Inc sold 12,504 shares as Novartis A G (NVS)’s stock rose 4.17%. The Boulegeris Investments Inc holds 3,086 shares with $225,000 value, down from 15,590 last quarter. Novartis A G now has $212.20 billion valuation. The stock increased 0.75% or $0.61 on June 19, reaching $81.44. About shares traded. Novartis AG (ADR) (NYSE:NVS) has risen 7.67% since June 20, 2016 and is uptrending. It has underperformed by 9.03% the S&P500.

Among 14 analysts covering Novartis Ag (NYSE:NVS), 4 have Buy rating, 2 Sell and 8 Hold. Therefore 29% are positive. Novartis Ag had 22 analyst reports since July 28, 2015 according to SRatingsIntel. Chardan Capital Markets initiated the stock with “Buy” rating in Tuesday, September 20 report. The rating was maintained by J P Morgan Chase Co on Friday, June 16 with “Neutral”. The firm has “Buy” rating given on Wednesday, March 8 by Societe Generale. The firm earned “Neutral” rating on Wednesday, April 19 by JP Morgan. The stock of Novartis AG (ADR) (NYSE:NVS) earned “Hold” rating by Argus Research on Tuesday, April 5. The stock of Novartis AG (ADR) (NYSE:NVS) has “Neutral” rating given on Thursday, March 23 by Goldman Sachs. JP Morgan downgraded the stock to “Neutral” rating in Tuesday, January 3 report. The rating was downgraded by Leerink Swann to “Market Perform” on Wednesday, March 23. The firm has “Neutral” rating by Citigroup given on Tuesday, March 29. Argus Research upgraded the stock to “Buy” rating in Thursday, November 10 report.

Boulegeris Investments Inc increased Johnson & Johnson (NYSE:JNJ) stake by 2,699 shares to 111,989 valued at $12.90 million in 2016Q4. It also upped Monmouth Real Estate Invt Co (NYSE:MNR) stake by 28,135 shares and now owns 2.34M shares. Jpmorgan Chase & Co (NYSE:JPM) was raised too.

Analysts await Novartis AG (ADR) (NYSE:NVS) to report earnings on July, 18. They expect $1.18 earnings per share, down 3.28% or $0.04 from last year’s $1.22 per share. NVS’s profit will be $3.07B for 17.25 P/E if the $1.18 EPS becomes a reality. After $1.13 actual earnings per share reported by Novartis AG (ADR) for the previous quarter, Wall Street now forecasts 4.42% EPS growth.

Since February 6, 2017, it had 0 insider purchases, and 9 insider sales for $9.31 million activity. 2,618 Baxter International Inc (NYSE:BAX) shares with value of $151,635 were sold by Shapazian Carole J. HELLMAN PETER S also sold $213,187 worth of Baxter International Inc (NYSE:BAX) on Wednesday, February 22. 4,280 shares valued at $206,938 were sold by FORSYTH JOHN D on Wednesday, February 8. GAVIN JAMES R III also sold $221,362 worth of Baxter International Inc (NYSE:BAX) shares. Eyre Brik V sold $7.28 million worth of stock or 130,732 shares. STROUCKEN ALBERT P L also sold $225,984 worth of Baxter International Inc (NYSE:BAX) shares. Shares for $596,490 were sold by STALLKAMP THOMAS T on Friday, May 5.

Penn Capital Management Co Inc decreased Jack In The Box Inc (NASDAQ:JACK) stake by 50,205 shares to 57,255 valued at $9.71M in 2016Q4. It also reduced Valvoline Inc stake by 40,851 shares and now owns 31,359 shares. Depomed Inc (NASDAQ:DEPO) was reduced too.

Among 13 analysts covering Baxter International (NYSE:BAX), 6 have Buy rating, 1 Sell and 6 Hold. Therefore 46% are positive. Baxter International had 25 analyst reports since July 30, 2015 according to SRatingsIntel. The company was reinitiated on Monday, August 10 by Credit Suisse. The rating was initiated by Barclays Capital with “Overweight” on Thursday, September 15. The stock of Baxter International Inc (NYSE:BAX) earned “Market Perform” rating by Leerink Swann on Thursday, July 30. The rating was initiated by Piper Jaffray with “Overweight” on Monday, November 16. The stock of Baxter International Inc (NYSE:BAX) earned “Overweight” rating by Barclays Capital on Tuesday, August 11. The rating was initiated by Wells Fargo with “Outperform” on Thursday, October 13. The firm has “Neutral” rating by JP Morgan given on Monday, June 6. The company was maintained on Wednesday, October 28 by Leerink Swann. RBC Capital Markets maintained it with “Sector Perform” rating and $40 target in Wednesday, February 3 report. The stock of Baxter International Inc (NYSE:BAX) earned “Neutral” rating by Credit Suisse on Monday, April 25.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: